Skip to main content
. 2022 May;11(5):738–747. doi: 10.21037/tp-22-139

Table 3. Analysis of glucocorticoid use and pulmonary imaging results on admission in SMPP.

Group n Inflammatory exudate*# Segmental opacities Massive consolidation χ2 P value
Glucocorticoid use 31 5 18 8
Normal treatment 28 9 17 2 2.196 0.042
Total 59 14 35 10

Compared with the number of segmental opacities, P*=0.319; compared with the number of massive consolidation, P#=0.032. SMPP, severe Mycoplasma pneumoniae pneumonia.